Client’s Testimonial:
Hi thank you! […] Yes, I will refer my friends to you.
On June 18th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Research Fellow in the Field of Chemistry (Approval Notice)
General Field: Chemistry
Position at the Time of Case Filing: Research Fellow
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: June 18th, 2015
Processing Time: 30 Days (Premium Processing Requested & RFE Response Time Included)
Case Summary:
In this case, the client that we had the opportunity to work with was a research fellow from China in the field of chemistry. Our client’s specialized research has focused on drug discovery and translational research through synthetic organic chemistry and inorganic chemistry. Her work had resulted in 12 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that her case was filed, her publications had been cited at least 308 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work. She had also reviewed 14 manuscripts for distinctive, internationally-circulated journals. Her superior level of expertise was confirmed in the following quote from an independent recommender, “She has made important contributions to efforts in drug discovery and oncology studies, including her development and analysis of new drug candidates for oncological treatments and diabetic foot ulcer treatments as well as methods for inflammatory disease detection. I have never had the opportunity to work with her personally, but I have been highly impressed with the results she has shared with the field through publications and presentations. I consider her to be an incredibly innovative, valuable member of the chemistry research community..” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of extraordinary ability, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 30 days.
We are pleased to announce that North America Immigration Law Group has so far received over 3,500 EB-1A, EB-1B and EB-2 NIW approval notices. In 2014 and 2015, the approval rate is 98.22% for cases using our "Approval or Refund®" (money back guarantee) service and 96.95% for all kinds of services.
For NIW cases, the approval rate is 99.18% for cases using our "Approval or Refund®" (money back guarantee) service and the overall approval rate for all NIW cases is 98.47%.
For EB1A cases, the approval rate is 97.25% for "Approval or Refund®" (money back guarantee) service and the overall approval rate for all EB1A cases is 95.27%.
We are one of the leading U.S. immigration law firms providing the most comprehensive services for EB-1/NIW petition with a large volume of approval cases and high approval rate.
Our staff keeps close track of the latest immigration trends and regulations of USCIS (U.S. Citizenship and Immigration Services), decisions of AAO (Administrative Appeal Office) and judicial review opinions. The massive collected materials contribute to the most convincing arguments and winning strategies of our firm for EB1A, EB1B, and NIW petitions.
If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.
Approval Notices: http://www.wegreened.com/eb1_niw_approvals
Success Stories: http://blog.wegreened.com/
Website: www.wegreened.com
Free evaluation email: law@wegreened.com
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.